Sonoma Pharmaceuticals (SNOA) FCF Margin (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly FCF Margin came in at 9.85% in Q1 2026, down 607.0% year-on-year from 1.94% in Q1 2025, and up 47.16% quarter-over-quarter from 18.65% in Q4 2025.
Sonoma Pharmaceuticals (SNOA) FCF Margin (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' FCF Margin history runs 17 years deep, the most recent figure standing at 9.85% for Q1 2026.
- On a quarterly basis, FCF Margin fell 607.0% year-over-year to 9.85% in Q1 2026; TTM through Mar 2026 was 21.12%, a 1995.0% decrease from a year earlier, with the FY2026 full-year figure at 21.12%, down 1995.0% from the prior year.
- FCF Margin rose to 9.85% in Q1 2026 per SNOA's latest filing, from 18.65% in the prior quarter.
- Across five years, FCF Margin topped out at 15.8% in Q4 2024 and bottomed at 87.29% in Q1 2023.
- The 5-year median for FCF Margin is 18.65% (2025), against an average of 25.84%.
- Across the five-year window, FCF Margin jumped 9224 bps in 2024 and sank 3444 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 12.87% in 2022, then slumped by 174 bps to 35.21% in 2023, then surged by 145 bps to 15.8% in 2024, then tumbled by 218 bps to 18.65% in 2025, then soared by 47 bps to 9.85% in 2026.
- Per Business Quant, the three latest SNOA FCF Margin figures stand at 9.85% (Q1 2026), 18.65% (Q4 2025), and 11.51% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -9.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.85% |
| Dec 31, 2025 | -18.65% |
| Sep 30, 2025 | -11.51% |
| Jun 30, 2025 | -52.83% |
| Mar 31, 2025 | -3.78% |
| Dec 31, 2024 | 15.80% |
| Sep 30, 2024 | 9.16% |
| Jun 30, 2024 | -27.04% |
| Mar 31, 2024 | 4.94% |
| Dec 31, 2023 | -35.21% |
| Sep 30, 2023 | -45.15% |
| Jun 30, 2023 | -6.77% |
| Mar 31, 2023 | -87.29% |
| Dec 31, 2022 | -12.87% |
| Sep 30, 2022 | -55.69% |
| Jun 30, 2022 | -39.07% |
| Mar 31, 2022 | -63.40% |
| Dec 31, 2021 | -11.27% |
| Sep 30, 2021 | -35.50% |
| Jun 30, 2021 | -34.53% |